drugset / Trial / NCT01669447

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis

NCT01669447

Phase 4 Unknown 20 enrolled Osias Francisco de Souza
NaSingle-groupOpen-labelSupportive care

Summary

Significant difference in the parameter settings of early optical coherence tomography (OCT spectal domain) in patients with subfoveal neovascular membrane realacionada age after treatment with a single intravitreal injection of Lucentis.

Timeline

Start
2012-09
Primary completion
2012-11
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranibizumab Monoclonal antibody Intravitreal